June 16, 2014
Stories this photo appears in:
U.S. District Court Judge David Carter of Santa Ana has declined a request from Valeant Pharmaceuticals International Inc., led by Chief Executive Mike Pearson, and activist investor Bill Ackman to dismiss a lawsuit accusing them of insider trading in shares of Allergan Inc.
Canada-based Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management are planning to hike their hostile bid to buy Irvine-based Allergan Inc. by $15 a share, according to a Wall Street Journal report today.
Canada-based Valeant Pharmaceuticals International Inc., which is attempting a hostile takeover of Irvine-based Allergan Inc., got a lift in early trading today after it released a preview of its results for the current quarter.
Irvine-based Allergan Inc. today released negative comments made about suitor Valeant Pharmaceuticals International Inc. by bankers with Morgan Stanley—one of the investment banks working for Valeant in its hostile $53 billion takeover attempt of Allergan.